Compare AU

Compare XALG vs. CURE

Compare shares and ETFs on the ASX that you can trade on Pearler.

Alphinity Global Equity Fund - Active ETF

ASX

Buy

Buy

Overview
Performance

Overview

When it comes to investing in the Australian stock market, shares and ETFs are a popular choice. Two options in the ASX are XALG and CURE. In this comparison, we'll delve into these options across various dimensions to help you make an informed investment decision.

Community Stats

XALG

CURE

Popularity

Low

Low

Pearlers invested

1

82

Median incremental investment

$993.50

$619.50

Median investment frequency

Daily

Monthly

Median total investment

$1,012.61

$1,323.41

Average age group

< 26

> 35


Key Summary

XALG

CURE

Strategy

XALG.AX was created on 2015-12-21 by Alphinity. The fund's investment portfolio concentrates primarily on total market equity. The Fund aims to outperform its benchmark after costs and over rolling three-year periods.

CURE.AX was created on 2018-11-08 by Global X. The fund's investment portfolio concentrates primarily on health care equity. The Fund aims to provide investors with a return that (before fees and expenses) tracks the performance of the S&P Biotechnology Select Industry Index.

Top 3 holdings

Alphinity Global Equity Fund - Active ETF (100 %)

Natera Inc (3.41 %)

Incyte Corp (2.94 %)

Gilead Sciences Inc (2.88 %)

Top 3 industries

Health Care (100.00 %)

Other (10.24 %)

Top 3 countries

United States (97.17 %)

Switzerland (1.51 %)

United Kingdom of Great Britain and Northern Ireland (1.16 %)

Management fee

0.75 %

0.45 %


Key Summary

XALG

CURE

Issuer

Alphinity

Global X

Tracking index

S&P Biotechnology Select Industry

Asset class

ETF

ETF

Management fee

0.75 %

0.45 %

Price

$12.18

$49.94

Size

N/A

$38.065 million

10Y return

N/A

N/A

Annual dividend/ distribution yield (5Y)

1.74 %

4.24 %

Market

ASX

ASX

First listed date

16/01/2023

12/11/2018

Purchase fee

$6.50

$6.50


Community Stats

XALG

CURE

Popularity

Low

Low

Pearlers invested

1

82

Median incremental investment

$993.50

$619.50

Median investment frequency

Daily

Monthly

Median total investment

$1,012.61

$1,323.41

Average age group

< 26

> 35


Pros and Cons

XALG

CURE

Pros

  • Higher price growth

  • Higher exposure to US market

  • Lower management fee

  • Higher distribution yield

Cons

  • Lower exposure to US market

  • Higher management fee

  • Lower distribution yield

  • Lower price growth

XALG

CURE

Lower exposure to US market

Higher exposure to US market

Higher management fee

Lower management fee

Higher price growth

Lower price growth

Lower distribution yield

Higher distribution yield

Home